| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-10 23:24:01 UTC |
|---|
| Update Date | 2021-09-26 22:55:25 UTC |
|---|
| HMDB ID | HMDB0246375 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline |
|---|
| Description | 4-(1,3-benzothiazol-2-yl)-2-methylaniline belongs to the class of organic compounds known as benzothiazoles. These are organic compounds containing a benzene fused to a thiazole ring (a five-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom). 4-(1,3-benzothiazol-2-yl)-2-methylaniline is a strong basic compound (based on its pKa). This compound has been identified in human blood as reported by (PMID: 31557052 ). 4-(1,3-benzothiazol-2-yl)-2-methylaniline is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically 4-(1,3-Benzothiazol-2-yl)-2-methylaniline is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CC1=C(N)C=CC(=C1)C1=NC2=CC=CC=C2S1 InChI=1S/C14H12N2S/c1-9-8-10(6-7-11(9)15)14-16-12-4-2-3-5-13(12)17-14/h2-8H,15H2,1H3 |
|---|
| Synonyms | | Value | Source |
|---|
| 2-(4-Amino-3-methylphenyl)benzothiazole | MeSH |
|
|---|
| Chemical Formula | C14H12N2S |
|---|
| Average Molecular Weight | 240.32 |
|---|
| Monoisotopic Molecular Weight | 240.072119568 |
|---|
| IUPAC Name | 4-(1,3-benzothiazol-2-yl)-2-methylaniline |
|---|
| Traditional Name | 4-(1,3-benzothiazol-2-yl)-2-methylaniline |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CC1=C(N)C=CC(=C1)C1=NC2=CC=CC=C2S1 |
|---|
| InChI Identifier | InChI=1S/C14H12N2S/c1-9-8-10(6-7-11(9)15)14-16-12-4-2-3-5-13(12)17-14/h2-8H,15H2,1H3 |
|---|
| InChI Key | IDBCUMFOZBUJCL-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzothiazoles. These are organic compounds containing a benzene fused to a thiazole ring (a five-membered ring with four carbon atoms, one nitrogen atom and one sulfur atom). |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Benzothiazoles |
|---|
| Sub Class | Not Available |
|---|
| Direct Parent | Benzothiazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,3-benzothiazole
- Aniline or substituted anilines
- Aminotoluene
- Toluene
- Benzenoid
- Monocyclic benzene moiety
- Thiazole
- Azole
- Heteroaromatic compound
- Azacycle
- Hydrocarbon derivative
- Organopnictogen compound
- Amine
- Primary amine
- Organonitrogen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 13.2947 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.53 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1793.7 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 401.5 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 153.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 219.4 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 148.6 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 422.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 458.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 116.5 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1186.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 367.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1026.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 338.1 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 352.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 368.7 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 274.5 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 65.5 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,1TMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N[Si](C)(C)C | 2657.3 | Semi standard non polar | 33892256 | | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,1TMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N[Si](C)(C)C | 2565.3 | Standard non polar | 33892256 | | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,1TMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N[Si](C)(C)C | 3005.4 | Standard polar | 33892256 | | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,2TMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N([Si](C)(C)C)[Si](C)(C)C | 2612.1 | Semi standard non polar | 33892256 | | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,2TMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N([Si](C)(C)C)[Si](C)(C)C | 2658.0 | Standard non polar | 33892256 | | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,2TMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N([Si](C)(C)C)[Si](C)(C)C | 2874.9 | Standard polar | 33892256 | | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,1TBDMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N[Si](C)(C)C(C)(C)C | 2896.4 | Semi standard non polar | 33892256 | | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,1TBDMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N[Si](C)(C)C(C)(C)C | 2804.5 | Standard non polar | 33892256 | | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,1TBDMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N[Si](C)(C)C(C)(C)C | 3105.0 | Standard polar | 33892256 | | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,2TBDMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3035.8 | Semi standard non polar | 33892256 | | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,2TBDMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3068.5 | Standard non polar | 33892256 | | 4-(1,3-Benzothiazol-2-yl)-2-methylaniline,2TBDMS,isomer #1 | CC1=CC(C2=NC3=CC=CC=C3S2)=CC=C1N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3021.1 | Standard polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - 4-(1,3-Benzothiazol-2-yl)-2-methylaniline GC-MS (Non-derivatized) - 70eV, Positive | splash10-01ox-0490000000-76999b561c1a847477be | 2021-09-24 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - 4-(1,3-Benzothiazol-2-yl)-2-methylaniline GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(1,3-Benzothiazol-2-yl)-2-methylaniline 10V, Positive-QTOF | splash10-0006-0090000000-8ce13bd4ca5c229243e8 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(1,3-Benzothiazol-2-yl)-2-methylaniline 20V, Positive-QTOF | splash10-0006-0090000000-96015feb5809c1657f76 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(1,3-Benzothiazol-2-yl)-2-methylaniline 40V, Positive-QTOF | splash10-00ko-1930000000-f18b973c3c4896182540 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(1,3-Benzothiazol-2-yl)-2-methylaniline 10V, Negative-QTOF | splash10-000i-0090000000-7e97a999964f97a0366d | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(1,3-Benzothiazol-2-yl)-2-methylaniline 20V, Negative-QTOF | splash10-000i-0090000000-50672050a5f6517efb02 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 4-(1,3-Benzothiazol-2-yl)-2-methylaniline 40V, Negative-QTOF | splash10-0a7r-1940000000-6fe77d3a5ac23b628e52 | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|